Bavarian Nordic AS (WBO:BAVA)
€ 27.94 0.26 (0.94%) Market Cap: 2.20 Bil Enterprise Value: 1.91 Bil PE Ratio: 22.91 PB Ratio: 1.55 GF Score: 54/100

Bavarian Nordic A/S RSV Human Challenge Trial Results Call Transcript

Sep 01, 2021 / 03:30PM GMT
Operator

Good afternoon, and thank you for standing by. Welcome to the Bavarian Nordic Conference Call. (Operator Instructions) I must advise you that this conference call is being recorded today.

I would now like to hand the conference over to your speaker, Mr. Rolf Sass. Please go ahead.

Rolf Sass SÃ;rensen;S;VP of IR;Communications
Bavarian Nordic A

¸ - /-&

Yes. Thank you, operator. Good morning to some, and good afternoon to the rest of you. We are excited to be back here already, again, this time to present our exciting results of the human challenge trial of our RSV project. And to do that, I have here our President and CEO, Paul Chaplin; Executive Vice President, CFO, Henrik Juuel, that will walk through a number of slides to discuss our trial results. And afterwards, of course, Q&A. We have the opportunity to ask all the questions you may have.

But before we walk through the presentation, I just want to read the following statements. This presentation includes forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot